| DEVCOM Chemical Biological Center | |
|---|---|
 | |
| Active | Unknown–present |
| Country |  United States |
| Branch |  United States Army |
| Type | Research and Development |
| Part of | Combat Capabilities Development Command, Army Futures Command |
| Garrison/HQ | Aberdeen Proving Ground, Maryland |
| Nickname(s) | DEVCOM CBC |
| Motto(s) | "Technology Driven. Warfighter focused." |
| Commanders | |
| Director | Mr. Michael Bailey |
The United States Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) is the United States Department of Defense's principal research and development resource for non-medical chemical and biological defense (CB).[1] As a critical national asset in the CB defense community, CBC supports all phases of the acquisition life-cycle ― from basic and applied research through technology development, engineering design, equipment evaluation, product support, sustainment, field operations and demilitarization ― to address its customers’ unique requirements.[2]
Its mission is to provide innovative chemical, biological, radiological, nuclear and explosive (CBRNE) defense capabilities to enable the joint warfighters' dominance on the battlefield and interagency defense of the homeland.
The DEVCOM Chemical Biological Center has more than 1,300 full-time employees located at three different sites in the United States: Edgewood Area of Aberdeen Proving Ground, Maryland; Pine Bluff Arsenal, Arkansas; and Rock Island Arsenal, Illinois. It has 1.22 million square feet of laboratory and test chamber space between its four research campuses.
DEVCOM also possesses a chemical munitions field operations capability. It consists of field-deployable scientists, engineers, technicians and explosives specialists with chemical/biological agent surety expertise plus unique capabilities for in situ destruction of agents. Finally, DEVCOM CBC develops smoke and obscurants technology, including synthesis, transport and dispersion.
DEVCOM CBC actively initiates agreements with industry to collaborate on applied research, product development and testing. It offers its partner companies the benefits of its intellectual property portfolio, science and engineering expertise, and its one-of-kind chemical biological research and testing infrastructure. Mechanisms for collaborative research, development and commercial production include Cooperative Research & Development Agreements (CRADAs), Letters of Intent (LOIs), Material Transfer Agreements (MTAs), Patent License Agreements (PLAs), Technology Support Agreements (TSAs) plus Memos of Agreement and Memos of Understanding.
